Skip to content
ApexRespiratory

Guide — Emergency Respiratory Care

Acute Respiratory Failure

When the lungs can no longer oxygenate or ventilate — the difference between Type I (hypoxemic) and Type II (hypercapnic) failure, what causes each, how to recognize impending failure, and the escalation ladder from oxygen to HFNC to NIV to intubation. The blood gas defines the type; recognizing it early and escalating in the right order prevents arrest.

10 min read · Emergency Respiratory Care

Written by Apex Respiratory Editorial Team

Educational use only. This material supports respiratory therapy education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional protocols, or physician orders. Always follow facility policies and current provider orders, and verify calculations independently before clinical use.

Overview

Acute respiratory failure is the inability of the respiratory system to maintain adequate gas exchange, and it is defined by the blood gas. Type I (hypoxemic) failure is a PaO₂ below 60 mmHg on room air; Type II (hypercapnic) failure is a PaCO₂ above 50 mmHg with a pH below 7.35 (acute). Recognizing it early and escalating support in the right order prevents arrest. Real management follows current guidelines and physician orders.

Key Concepts — Two Types of Failure

Type I versus Type II respiratory failure
TypeDefinitionMechanismA-a GradientCommon Causes
Type I (hypoxemic)PaO₂ < 60 mmHgV/Q mismatch & shuntElevated A-a gradientPneumonia, pulmonary edema, ARDS, atelectasis, pulmonary embolism
Type II (hypercapnic)PaCO₂ > 50 mmHg, pH < 7.35“Pump” / ventilatory failureOften normal in pure hypoventilationWon't breathe (opioids, CNS injury), can't breathe (neuromuscular weakness), or excessive load (COPD, severe asthma, obstruction)
  • Type I (hypoxemic / oxygenation failure): PaO₂ under 60 mmHg despite supplemental oxygen. V/Q mismatch and shunt dominate (pneumonia, pulmonary edema, ARDS, atelectasis, pulmonary embolism), so the A-a gradient is elevated.
  • Type II (hypercapnic / ventilatory failure): PaCO₂ over 50 mmHg with respiratory acidosis. This is “pump” failure — the patient will not breathe (depressed drive from opioids or CNS injury), cannot breathe (neuromuscular weakness such as Guillain-Barre or myasthenia, or muscle fatigue), or faces an excessive load (COPD, severe asthma, airway obstruction). The A-a gradient is often normal in pure hypoventilation.
  • Acute vs chronic vs acute-on-chronic: the pH tells you. A chronic CO₂ retainer is compensated with a near-normal pH; acute decompensation drops the pH below 7.35.
  • Mechanisms of hypoxemia. V/Q mismatch, shunt, hypoventilation, and diffusion limitation — and whether the hypoxemia corrects with oxygen — help localize the cause.

Assessment & Findings

  • Early or compensated: tachypnea, tachycardia, accessory muscle use, anxiety, mild hypoxemia, and a respiratory alkalosis from blowing off CO₂.
  • Decompensating or impending arrest: a rising or “normalizing” CO₂ in a tiring patient (a normal CO₂ in a severe asthmatic is ominous), declining level of consciousness, a falling respiratory rate, paradoxical breathing, a silent chest, cyanosis, and bradycardia.
  • Read the ABG together with the clinical picture, and trend it.

RT Priorities & Interventions — The Escalation Ladder

Escalation ladder for acute respiratory failure
StepInterventionBest ForNotes
1OxygenHypoxemiaTarget SpO₂ 92-96% (or 88-92% in chronic hypercapnia)
2HFNCHypoxemic failureNot meeting target on oxygen, or increased work of breathing
3NIV (BiPAP)Hypercapnic failureBest in COPD with respiratory acidosis & cardiogenic pulmonary edema; needs intact drive, airway, cooperation
4Intubation & mechanical ventilationWhen the above failMental status declines, airway unprotected, or patient apneic
  1. Oxygen for hypoxemia. Target SpO₂ 92-96%, or 88-92% in chronic hypercapnia.
  2. High-flow nasal cannula (HFNC). For hypoxemic failure not meeting target or with increased work of breathing.
  3. Noninvasive ventilation (NIV/BiPAP). For hypercapnic failure — best evidence in COPD with respiratory acidosis and in cardiogenic pulmonary edema — when the patient has an intact drive and airway and is cooperative.
  4. Intubation and mechanical ventilation. When the above fail, mental status declines, the airway is unprotected, or the patient becomes apneic.
  5. Treat the underlying cause at the same time — bronchodilators, diuretics, antibiotics, reversal agents. Real emergencies follow current ACLS/protocol and physician orders.

Common Pitfalls

  • Taking reassurance from a “normalizing” CO₂ or respiratory rate in a tiring patient — it signals fatigue, not improvement.
  • Using NIV in a patient who cannot protect the airway or has a depressed mental status (aspiration risk) — do not delay intubation.
  • Withholding oxygen from a hypoxemic hypercapnic patient out of hypoxic-drive fear — titrate to SpO₂ 88-92% instead.
  • Treating the number rather than the trajectory.

Board Exam Pearls

  • Type I = PaO₂ under 60 mmHg (oxygenation); Type II = PaCO₂ over 50 with pH under 7.35 (ventilation).
  • A rising or normalizing CO₂ in a fatiguing asthmatic signals impending failure.
  • Escalation: oxygen, then HFNC, then NIV, then intubation.
  • NIV has the best evidence in COPD exacerbation with respiratory acidosis and in cardiogenic pulmonary edema.
  • Hypercapnic failure is pump failure: will not breathe, cannot breathe, or too much load.

FAQ

What is the difference between Type I and Type II respiratory failure?

Type I is oxygenation failure — a PaO₂ below 60 mmHg driven by V/Q mismatch and shunt (pneumonia, edema, ARDS). Type II is ventilatory (pump) failure — a PaCO₂ above 50 with acidosis, from a failing drive, neuromuscular weakness, or an overwhelming load such as COPD. A patient can have both at once.

Why is a normal CO₂ worrying in a severe asthma attack?

Early in an attack the patient hyperventilates and the CO₂ is low. As they tire and airflow falls, the CO₂ climbs back toward and past normal — so a “normal” CO₂ in a visibly exhausted asthmatic means they are failing, not recovering.

How do I choose between HFNC, NIV, and intubation?

HFNC suits hypoxemic failure with preserved ventilation. NIV (BiPAP) suits hypercapnic failure — especially COPD with respiratory acidosis and cardiogenic pulmonary edema — when the patient is awake, cooperative, and can protect the airway. Intubate when those fail, mental status declines, or the airway is unprotected.

Should NIV be used in an obtunded patient?

Generally no. A depressed mental status, inability to protect the airway, vomiting, or hemodynamic instability are contraindications — NIV risks aspiration and delays definitive airway control. Intubate instead.

Put it to work

The blood gas defines the type of failure. Practice reading the acid-base and oxygenation picture.

Open the ABG Interpreter →

Related Resources

Sources

  1. Kacmarek RM, Stoller JK, Heuer AJ. Egan's Fundamentals of Respiratory Care. 12th ed. Elsevier; 2021. Respiratory failure and ventilatory support chapters.
  2. Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426.